Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 3 May 2011
Vol. 4, Issue 171, p. ra28
[DOI: 10.1126/scisignal.2001486]
RESEARCH ARTICLES
Editor's Summary
Beneficial Bias
A successful vaccine adjuvant must stimulate the immune system without triggering harmful inflammatory side effects. Stimulation of Toll-like receptor 4 (TLR4) by lipopolysaccharide (LPS) induces a toxic inflammatory response, characterized by induction and assembly of the NLRP3 inflammasome and production of the proinflammatory cytokine interleukin-1β (IL-1β). TLR4 signaling in response to the LPS derivative monophosphoryl lipid A (MLA) is orders of magnitude less toxic than that stimulated by LPS; however, how these compounds elicit such different responses through the same receptor is unclear. Embry et al. provide evidence that MLA induced one arm of TLR4 signaling (through the adaptor protein TRIF), such that small quantities of the precursor form of IL-1β were synthesized, but that induction and assembly of the inflammasome and production of active IL-1β were defective. These processes instead depended on the second arm of TLR4 signaling, mediated by the adaptor MyD88, which was only activated by LPS. In addition, priming of cells with MLA dampened subsequent TLR4-dependent responses because of failed assembly of the inflammasome. Together, these data highlight a potential mechanism for the beneficial effects of MLA.
Citation: C. A. Embry, L. Franchi, G. Nuñez, T. C. Mitchell, Mechanism of Impaired NLRP3 Inflammasome Priming by Monophosphoryl Lipid A. Sci. Signal.4, ra28 (2011).
Rosetta Merline, Kristin Moreth, Janet Beckmann, Madalina V. Nastase, Jinyang Zeng-Brouwers, José Guilherme Tralhão, Patricia Lemarchand, Josef Pfeilschifter, Roland M. Schaefer, Renato V. Iozzo, and Liliana Schaefer (15 November 2011) Sci. Signal.4 (199), ra75.
[DOI: 10.1126/scisignal.2001868] |Editor's Summary »|Abstract »|Full Text »|PDF »|Supplementary Materials »
EDITORS' CHOICE
John F. Foley (4 October 2011) Sci. Signal.4 (193), ec274.
[DOI: 10.1126/scisignal.4193ec274] |Abstract »
EDITORS' CHOICE
John F. Foley (21 June 2011) Sci. Signal.4 (178), ec171.
[DOI: 10.1126/scisignal.4178ec171] |Abstract »
PODCASTS
Thomas C. Mitchell and Annalisa M. VanHook (3 May 2011) Sci. Signal.4 (171), pc9.
[DOI: 10.1126/scisignal.2002075] |Abstract »|Full Text »|Podcast »
TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in mice.
M. Pihlgren, A. B. Silva, R. Madani, V. Giriens, Y. Waeckerle-Men, A. Fettelschoss, D. T. Hickman, M. P. Lopez-Deber, D. M. Ndao, M. Vukicevic, et al. (2013)
Blood
121, 85-94
|Abstract »|Full Text »|PDF »
Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist.
W. S. Bowen, L. A. Minns, D. A. Johnson, T. C. Mitchell, M. M. Hutton, and J. T. Evans (2012)
Science Signaling
5, ra13
|Abstract »|Full Text »|PDF »
Science Signaling Podcast: 3 May 2011.
T. C. Mitchell and A. M. VanHook (2011)
Science Signaling
4, pc9
|Abstract »|Full Text »